GOALS

• Identify and invest in promising drug candidates that address significant unmet medical needs and hold the potential to improve human health
• Accelerate drug development timelines and bring novel therapies to market faster by leveraging innovative technologies and streamlining clinical trial processes
• Drive profitability and shareholder value by developing commercially successful drugs with a strong competitive advantage in the market.

Frustrations

• Dealing with lengthy clinical trial timelines and unexpected delays, which can impact drug development budgets and timelines to market
• Facing challenges in recruiting and retaining diverse patient populations for clinical trials, hindering the generalizability of research findings
• Managing the complexities of global clinical trials, including navigating different regulatory environments and ensuring compliance across multiple sites.

GOALS

• Empower patients with knowledge and resources about clinical trials, helping them make informed decisions about their participation in research studies
• Advocate for increased patient diversity in clinical trials to ensure that research findings are relevant and applicable to a wider range of populations
• Improve the patient experience in clinical trials by advocating for patient-centric practices and reducing barriers to participation such as travel time and costs.

Frustrations

• Witnessing disparities in access to clinical trials, particularly among underrepresented communities due to factors like language barriers, socioeconomic status, or lack of trust in the healthcare system
• Encountering misinformation and distrust surrounding clinical trials, making it challenging to engage potential participants and address their concerns effectively
• Observing the emotional and physical burden that traditional clinical trials can place on patients, highlighting the need for more convenient and accessible trial designs.